Assessing the Role of Rare Genetic Variation in Patients With Heart Failure
Gundula Povysil(Bridgepoint (United States)), David B. Goldstein(Electronic BioSciences (United States)), Christopher B. Granger(Clinical Research Institute), Dirk S. Paul(AstraZeneca (United Kingdom)), John Kjekshus(Nuffield Health), Carolina Haefliger(AstraZeneca (United Kingdom)), Olympe Chazara(AstraZeneca (United Kingdom)), Vimla S. Aggarwal(Columbia University Irving Medical Center), Quanli Wang, Javier Armisen, Sri V. V. Deevi(University of Cambridge), Keren Carss(AstraZeneca (United Kingdom))
Cited by 76
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
|New England Journal of Medicine|2019|1.9k